Cryoablation has been reported as an effective treatment for abnormal uterine bleeding in the short term, but longer-term data have been lacking. New data from Raffaele Bruno, MD, and a research team at Lahey Clinic in Burlington, MA, indicate that cryoabalation is also effective into the second year after treatment.
Cryoablation has been reported as an effective treatment for abnormal uterine bleeding in the short term, but longer-term data have been lacking. New data from Raffaele Bruno, MD, and a research team at Lahey Clinic in Burlington, MA, indicate that cryoabalation is also effective into the second year after treatment.
The group followed a cohort of 112 women who underwent cryoablation. Clinicians used a modified technique based on the size of the uterus. The freeze pattern was 7 x 7 for uteri less than 9 cm and 7 x 7 x 4 for larger organs.
The entire cohort of 112 women returned for 1-year follow-up and 106 returned for a 2-year evaluation. The patients were assessed for bleeding status and any adverse events associated with treatment.
At the 1-year follow-up, 92% of patients reported successful results, either achieving eumenorrhea or improved bleeding patterns. At the 2-year mark, 90% of women reported similar success. Just under half of patients, 47%, reported either amenorrhea or spotting during the 2-year assessment. Only 10 patients reported treatment failure, six of whom underwent hysterectomy without complications. The other four women declined further treatment.
Bruno R, Hurd JK, Soto-Wright V, McLellan R. Two-year continuous effects of endometrial cryoablation for the treatment of menometrorrhagia. Obstet Gynecol. 2005;105(4 suppl):65S.
Chemoattractants in fetal membranes enhance leukocyte migration near term pregnancy
November 22nd 2024A recent study highlights the release of chemoattractants from human fetal membranes at term, driving leukocyte activation and migration, with implications for labor and postpartum recovery.
Read More
Reproductive genetic carrier screening: A tool for reproductive decision-making
November 22nd 2024A new study highlights the efficacy of couple-based reproductive genetic carrier screening in improving reproductive decisions and outcomes, emphasizing its growing availability and acceptance among diverse populations.
Read More
Early preterm birth risk linked to low PlGF levels during pregnancy screening
November 20th 2024New research highlights that low levels of placental growth factor during mid-pregnancy screening can effectively predict early preterm birth, offering a potential tool to enhance maternal and infant health outcomes.
Read More